Delivery Order SPE2DB22D3010-SPE2DB25FP3EQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Pediarix HIB vaccine in 0.5ML vials, with a ceiling value of $1,938.38. This firm fixed price delivery order, which is due for completion by August 26, 2025, represents a competitively awarded non-set-aside contract supporting federal medical procurement needs. The order will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,462.95 to AmerisourceBergen Drug Corp for the supply of Pediarix/PedvaxHIB vaccine vials (0.5 mL) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is listed as the...
- The Defense Logistics Agency awarded a $4,949.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Pediarix HIB vaccine in 0.5mL vials. Issued on August 11, 2025, with an ultimate completion date of August 12, 2025, this competitively awarded contract (no set-aside used) will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,115.70 to AmerisourceBergen Drug Corp for the supply of Pediarix HIB vaccine in 0.5ML vials. The contract, which was competitively awarded with no set-aside designation, carries a firm fixed price structure and an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Pediarix (Hib) vaccine in 0.5 mL vials, with a ceiling value of $1,324.88 and an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pediarix HIB vaccine in 0.5 milliliter vials, with a ceiling value of $1,326.85 and an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,237.16 to AmerisourceBergen Drug Corp for the supply of Pediarix HIB vaccine in 0.5ML vials. This is a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and no set-aside designation was used in the award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's extensive pharmaceutical distribution capabilities and...
- The Defense Logistics Agency awarded a delivery order valued at $5,206.60 to AmerisourceBergen Drug Corp for the supply of Pediarix HIB vaccine in 0.5 milliliter vials. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Pediarix HB vaccine in 0.5 mL vials with a ceiling value of $1,137.54. This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle. The award was made on a competitive basis without any set-aside designation, and performance will be...
- The U.S. Defense Logistics Agency awarded a $3,663.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pediarix vaccine vials (0.5mL) on August 7, 2025, with completion expected by August 8, 2025. This is a competitive award with no set-aside designation, representing a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3EQDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,164.10 on August 12, 2025, for the supply of Pediarix HIB vaccine in 0.5mL vials. This contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract is scheduled for ultimate completion on August 13, 2025, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting military healthcare operations. AmerisourceBergen's comprehensive prime IDV with DLA serves as the vehicle for supplying a wide range of pharmaceutical products and medical supplies to Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. As a major pharmaceutical distributor, AmerisourceBergen fulfills critical medical supply needs across multiple therapeutic domains through the DLA Medical Supply Chain, enabling flexible and efficient vaccine distribution to support military readiness and personnel health requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/12/25 |